1
|
Mendez Y, Alpuing Radilla LA, Delgadillo Chabolla LE, Castillo Cruz A, Luna J, Surani S. Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic. World J Diabetes 2023; 14:1178-1193. [PMID: 37664480 PMCID: PMC10473953 DOI: 10.4239/wjd.v14.i8.1178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/28/2023] [Revised: 06/24/2023] [Accepted: 07/17/2023] [Indexed: 08/11/2023] Open
Abstract
During the global coronavirus disease 2019 (COVID-19) pandemic, people worldwide have experienced an unprecedented rise in psychological distress and anxiety. In addition to this challenging situation, the prevalence of diabetes mellitus (DM), a hidden epidemic, has been steadily increasing in recent years. Lower-middle-income countries have faced significant barriers in providing accessible prenatal care and promoting a healthy diet for pregnant women, and the pandemic has made these challenges even more difficult to overcome. Pregnant women are at a higher risk of developing complications such as hyper-tension, preeclampsia, and gestational diabetes, all of which can have adverse implications for both maternal and fetal health. The occurrence of gestational diabetes has been on the rise, and it is possible that the pandemic has worsened its prevalence. Although data is limited, studies conducted in Italy and Canada suggest that the pandemic has had an impact on gestational diabetes rates, especially among women in their first trimester of pregnancy. The significant disruptions to daily routines caused by the pandemic, such as limited exercise options, indicate a possible link between COVID-19 and an increased likelihood of experiencing higher levels of weight gain during pregnancy. Notably, individuals in the United States with singleton pregnancies are at a significantly higher risk of excessive gestational weight gain, making this association particularly important to consider. Although comprehensive data is currently lacking, it is important for clinical researchers to explore the possibility of establishing correlations between the stress experienced during the pandemic, its consequences such as gestational gain weight, and the increasing incidence of gestational DM. This knowledge would contribute to better preventive measures and support for pregnant individuals during challenging times.
Collapse
Affiliation(s)
- Yamely Mendez
- Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030, United States
| | - Linda A Alpuing Radilla
- Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030, United States
| | | | - Alejandra Castillo Cruz
- Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030, United States
| | - Johanan Luna
- Department of Medicine, Xochicalco University, Mexicali 21376, BC, Mexico
- Department of Medicine, Mt. Olympus Medical Research, Sugarland, TX 77479, United States
| | - Salim Surani
- Department of Medicine & Pharmacology, Texas A&M University, College Station, TX 77843, United States
| |
Collapse
|
2
|
Jésus P, Fayemendy P, Marin B, Lautrette G, Labrunie A, Preux PM, Luna J, Desport JC, Couratier P. Impact sur l’état fonctionnel d’une complémentation nutritionnelle oral (CNO) précoce des patients atteints de sclérose latérale amyotrophie (SLA) : étude nationale multicentrique NUTRALS. NUTR CLIN METAB 2022. [DOI: 10.1016/j.nupar.2021.12.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
3
|
Hernandez-Guerrero T, Doger B, Luna J, Azinovich I, Moreno V. Positioning of hafnium oxide nanoparticles therapy in cancer treatment. DRUG FUTURE 2022. [DOI: 10.1358/dof.2022.47.5.3369189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Karp F, Busatto C, Turino L, Luna J, Estenoz D. PLGA nano- and microparticles for the controlled release of florfenicol: Experimental and theoretical study. J Appl Polym Sci 2018. [DOI: 10.1002/app.47248] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- F. Karp
- Instituto de Desarrollo Tecnológico para la Industria Química; INTEC (Universidad Nacional del Litoral and CONICET); Güemes 3450, Santa Fe 3000 Argentina
| | - C. Busatto
- Instituto de Desarrollo Tecnológico para la Industria Química; INTEC (Universidad Nacional del Litoral and CONICET); Güemes 3450, Santa Fe 3000 Argentina
| | - L. Turino
- Instituto de Desarrollo Tecnológico para la Industria Química; INTEC (Universidad Nacional del Litoral and CONICET); Güemes 3450, Santa Fe 3000 Argentina
| | - J. Luna
- Instituto de Desarrollo Tecnológico para la Industria Química; INTEC (Universidad Nacional del Litoral and CONICET); Güemes 3450, Santa Fe 3000 Argentina
| | - D. Estenoz
- Instituto de Desarrollo Tecnológico para la Industria Química; INTEC (Universidad Nacional del Litoral and CONICET); Güemes 3450, Santa Fe 3000 Argentina
| |
Collapse
|
5
|
Rodriguez de dios N, Couñago F, López J, Calvo P, Murcia M, Rico M, Vallejo C, Luna J, Cigarral C, Trueba I, Farre N, Manero R, Duran X, Samper P. OC-0498: Randomized phase III trial of PCI with or without hippocampal avoidance for SCLC. Goecpseorgicor. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)30808-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
6
|
Rodriguez De Dios N, Sanchez E, Otero A, Lopez J, Luna J, Delgado R, López M, Cenizo E, Monroy J. EP-1356: Radical Accelerated Hypofractionated 3d-CRT In NSCLC Patients on behalf of GOECP-SEOR. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31665-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
7
|
Penedo J, Luna J, Garcia M, Olivera J, Gomez-Tejedor S, Rincon M, Aguilar K, Gomez I, Sanchez L, Diaz C, Vasquez W, Vara J. Positioning Accuracy for Frameless Lung SBRT Using 4-Dimensional Cone Beam CT Guidance. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.2312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
8
|
Gilder D, Moore R, Geisler J, Calac D, Luna J, Ehlers C. Prevention of underage drinking and alcohol use disorders in native American adolescents: Influence of stress and dark side symptoms. Alcohol 2017. [DOI: 10.1016/j.alcohol.2017.02.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
9
|
Luna J, Ilundain A, Gómez-Tejedor S, Esteban D, Rincón M, Olivera J, Vásquez W, Prieto I, Guzmán L, Vara J. EP-1432: Advantage of butterfly-vmat versus vmat in mediastinal tumors. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31867-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Luna J, Logroscino G, Couratier P, Marin B. Current issues in ALS epidemiology: Variation of ALS occurrence between populations and physical activity as a risk factor. Rev Neurol (Paris) 2017; 173:244-253. [DOI: 10.1016/j.neurol.2017.03.035] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2017] [Revised: 03/29/2017] [Accepted: 03/31/2017] [Indexed: 11/16/2022]
|
11
|
Rincon M, Olivera J, Penedo J, Prieto I, Gomez S, Garcia M, Luna J, Esteban D, Ilundain A, Vara J. EP-1074: Dose impact using standard head and neck immobilization system in brain tumours. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31510-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
12
|
Busatto CA, Labie H, Lapeyre V, Auzely-Velty R, Perro A, Casis N, Luna J, Estenoz DA, Ravaine V. Oil-in-microgel strategy for enzymatic-triggered release of hydrophobic drugs. J Colloid Interface Sci 2017; 493:356-364. [PMID: 28126608 DOI: 10.1016/j.jcis.2017.01.029] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2016] [Revised: 01/06/2017] [Accepted: 01/09/2017] [Indexed: 01/28/2023]
Abstract
Polymer microgels have received considerable attention due to their great potential in the biomedical field as drug delivery systems. Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan composed of N-acetyl-d-glucosamine and d-glucuronic acid. This polymer is biodegradable, nontoxic, and can be chemically modified. In this work, a co-flow microfluidic strategy for the preparation of biodegradable HA microgels encapsulating hydrophobic drugs is presented. The approach relies on: (i) generation of a primary oil-in-water (O/W) nanoemulsion by the ultrasonication method, (ii) formation of a double oil-in-water-in-oil emulsion (O/W/O) using microfluidics, and (iii) cross-linking of microgels by photopolymerization of HA precursors modified with methacrylate groups (HA-MA) present in the aqueous phase of the droplets. The procedure is used for the encapsulation and controlled release of progesterone. Degradability and encapsulation/release studies in PBS buffer at 37°C in presence of different concentrations of hyaluronidase are performed. It is demonstrated that enzymatic degradation can be used to trigger the release of progesterone from microgels. This method provides precise control of the release system and can be applied for the encapsulation and controlled release of different types of hydrophobic drugs.
Collapse
Affiliation(s)
- C A Busatto
- Instituto de Desarrollo Tecnológico para la Industria Química, INTEC (Universidad Nacional del Litoral and CONICET), Güemes 3450, 3000 Santa Fe, Argentina
| | - H Labie
- Université de Bordeaux, Bordeaux INP, ISM, UMR 5255, Site ENSCBP, 16 avenue Pey Berland, 33607 Pessac, France
| | - V Lapeyre
- Université de Bordeaux, Bordeaux INP, ISM, UMR 5255, Site ENSCBP, 16 avenue Pey Berland, 33607 Pessac, France
| | - R Auzely-Velty
- Centre de Recherches sur les Macromolécules Végétales (CERMAV-CNRS), affiliated with Université Joseph Fourier, 601 rue de la Chimie, 38041 Grenoble, France
| | - A Perro
- Université de Bordeaux, Bordeaux INP, ISM, UMR 5255, Site ENSCBP, 16 avenue Pey Berland, 33607 Pessac, France
| | - N Casis
- Instituto de Desarrollo Tecnológico para la Industria Química, INTEC (Universidad Nacional del Litoral and CONICET), Güemes 3450, 3000 Santa Fe, Argentina
| | - J Luna
- Instituto de Desarrollo Tecnológico para la Industria Química, INTEC (Universidad Nacional del Litoral and CONICET), Güemes 3450, 3000 Santa Fe, Argentina
| | - D A Estenoz
- Instituto de Desarrollo Tecnológico para la Industria Química, INTEC (Universidad Nacional del Litoral and CONICET), Güemes 3450, 3000 Santa Fe, Argentina
| | - V Ravaine
- Université de Bordeaux, Bordeaux INP, ISM, UMR 5255, Site ENSCBP, 16 avenue Pey Berland, 33607 Pessac, France.
| |
Collapse
|
13
|
Vegas JO, Rincón M, Vasquez W, Garcia M, Perez A, Vara J, Luna J, Prieto I, Tejedor SG, Penedo J, Esteban D, Ilundain A. Accuracy Treatments With Frameless Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
14
|
Nizard M, Luna J, Cruz M, Houinato D, Ratsimbazafy V, Preux PM. Identification des barrières d’accessibilité aux antiépileptiques dans deux pays en développement. Rev Epidemiol Sante Publique 2016. [DOI: 10.1016/j.respe.2016.06.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
15
|
Couñago F, Rodríguez A, Calvo P, Luna J, Monroy JL, Taboada B, Díaz V, Rodríguez de Dios N. Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society). Clin Transl Oncol 2016; 19:31-43. [PMID: 27106020 DOI: 10.1007/s12094-016-1512-2] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2016] [Accepted: 04/09/2016] [Indexed: 02/06/2023]
Abstract
In recent years, major advances in our understanding of the molecular biology of lung cancer, together with significant improvements in radiotherapy technologies, have revolutionized the treatment of non-small cell lung cancer (NSCLC). This has led to the development of new therapies that target molecular mutations specific to each tumor type, acting on the cell surface antigens or intracellular signaling pathways, or directly affecting cell survival. At the same time, ablative dose radiotherapy can be delivered safely in the context of metastatic disease. In this article, the GOECP/SEOR (Oncological Group for Study of Lung Cancer/Spanish Society of Radiation Oncology) reviews the role of new targeted therapies used in combination with radiotherapy in patients with locally advanced (stage III) NSCLC and in patients with advanced, metastatic (stage IV) NSCLC.
Collapse
Affiliation(s)
- F Couñago
- Department of Radiation Oncology, Hospital Universitario Quirón, Calle Diego de Velázquez, 1, 28223, Pozuelo de Alarcón, Madrid, Spain
| | - A Rodríguez
- Department of Radiation Oncology, Hospital Ruber Internacional, Calle de la Masó, 38, 28034, Madrid, Spain
| | - P Calvo
- Department of Radiation Oncology, Hospital Universitario Santiago de Compostela, Travesía de Choupana, s/n, 15706, Santiago de Compostela, Spain
| | - J Luna
- Department of Radiation Oncology, Hospital Universitario Fundación Jiménez Díaz, Avda. Reyes Católicos, 2, 28040, Madrid, Spain
| | - J L Monroy
- Department of Radiation Oncology, Hospital Universitario La Ribera, Carretera de Corbera, km 1, 46600, Alzira, Valencia, Spain
| | - B Taboada
- Department of Radiation Oncology, Hospital Universitario Santiago de Compostela, Travesía de Choupana, s/n, 15706, Santiago de Compostela, Spain
| | - V Díaz
- Department of Radiation Oncology, Hospital Universitario Puerta del Mar, Av. Ana de Viya, 21, 11009, Cádiz, Spain
| | - N Rodríguez de Dios
- Department of Radiation Oncology, Hospital de la Esperanza, Parc de Salut Mar, Barcelona, Spain. .,IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. .,Universitat Pompeu Fabra, San josé de la Montaña 12, 08024, Barcelona, Spain.
| |
Collapse
|
16
|
Prieto I, Luna J, Marin J, Diaz C, Olivera J, Vara J, Almeida G, Perez A, Pardo J. Effective and Accurate Radiation Therapy Regardless of Painful Procedures and Breakthrough Pain Episodes. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
17
|
Olivera J, Penedo J, Marin J, Garcia Castejon M, Diaz Silvera C, Prieto I, Luna J, Vasquez W, Perez Casas A. Localized Prostate Cancer: Volumetric Modulated Arc Therapy (VMAT) Versus Intensity Modulated Radiation Therapy (IMRT)–Which One is Better? Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
18
|
Liapikou A, Polverino E, Cilloniz C, Peyrani P, Ramirez J, Menendez R, Torres A, Nakamatsu R, Arnold F, Allen M, Broch G, Bordon J, Gross P, Weiss K, Legnani D, Bodi M, Porras J, Torres A, Lode H, Roig J, Benchetrit G, Gonzalez J, Videla A, Corral J, Martinez J, Rodriguez E, Rodriguez M, Victorio C, Levy G, Arteta F, Fuenzalida AD, Parada M, Luna J. A Worldwide Perspective of Nursing Home-Acquired Pneumonia Compared With Community-Acquired Pneumonia. Respir Care 2013; 59:1078-85. [DOI: 10.4187/respcare.02788] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
19
|
Prieto I, Pardo J, Marin J, Luna J, Mena A, Olivera J, Diaz C, Perez A, Almeyda G. Fentanyl Pectin Nasal Citrate to Control Breakthrough Pain Provoked by Routine Radiation Therapy Procedures and Maneuvers in Advanced Cancer Patients. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
20
|
Prieto I, Pardo J, Marin J, Luna J, Mena A, Olivera J, Diaz C, Chavez A, Perez A, Almeyda G. Fentanyl pectin nasal citrate to control breakthrough pain in procedures. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
21
|
Prieto I, Vara J, Olivera J, Pardo J, Luna J, Perez A, Marin J, Chavez A, Diaz C. Checklists implementation in radiotherapy: Is it useful? Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
22
|
Prieto I, Olivera J, Pardo J, Vara J, Luna J, Pérez A, Marin J, Díaz C, Chavez A. Radiotherapy patient safety. Are RD 1566/1998 and 815/2001 enough? Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
23
|
Pardo J, Mena A, Prieto I, Noé A, Luna J, Vara J, Granados Plaza M, Diaz Herrera M, Pérez A. Breast cancer hypofractionated radiotherapy: Observational study of toxicity and outcome. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
24
|
Prieto I, Pardo J, Marin J, Olivera J, Vara J, Luna J, Perez A, Diaz C, Chavez A. Map of risks development to improve patient's safety in radiotherapy. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
25
|
Marín J, Olivera J, Pérez A, Chávez A, Díaz C, Penedo J, Luna J, Prieto I, Quicios C, Lopez L. Brachytherapy with 125-I seeds for prostate carcinoma: Learning curve. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
26
|
Pardo J, Mena A, Prieto I, Noe A, Alvarado A, Luna J, Vara J, Pérez A. PO-0911: Acute toxicity and cosmetic outcome in 294 breast cancer patients treated with hypofractionated radiotherapy. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33217-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
27
|
Prieto I, Pardo J, Marin J, Luna J, Olivera J, Pérez A. PO-0921: Fentanyl pectin nasal citrate to control breakthrough pain provoked by radiotherapy procedures in cancer patients. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33227-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
28
|
Mena A, Pardo J, Noé A, Alvarado A, Feltes N, Vara J, Prieto I, Olivera J, Luna J, Perez A. Acute Toxicity and Cosmetic Outcome Evaluation in 294 Breast Cancer Patients (pts) Treated With Hypofractionated Radiation Therapy (HPRT) After Conservative Surgery. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
29
|
Prieto I, Pardo J, Perez-Casas A, Olivera J, Luna J, Vara J. Fentanyl Pectin Nasal Citrate (FPNC) to Control Breakthrough Pain (BP) and Improve Dysphagia in Head-and-Neck Cancer Patients Receiving Radiation Therapy (RT). Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1378] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
30
|
Vegas JO, Chavez A, Iglesias M, Luna J, Vara J, Prieto I, Perez A, Alvarado A, Feltes N, Pardo J. EP-1093 PREVENTING LATE RECTAL AND URINARY TOXICITIES WITH GLUTAMINE IN PROSTATE CANCER PATIENTS TREATED WITH RADIOTHERAPY. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71426-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
31
|
Prieto I, Díaz C, Pardo J, Luna J, Casas AP. EP-1163 INCIDENCE OF TOXICITY IN LOCALLY ADVANCED HEAD? NECK CANCER PTS (LAHNSCC) TREATED WITH CETUXIMAB PLUS RADIOTHERAPY. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71496-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Iglesias T, Olivera J, García M, Luna J, Vara J, Prieto I, Chávez A, Díaz C, López L, Casas AP. EP-1339 ANALYSIS OF DVH AND ACUTE TOXICITY IN RECTUM AND URETHRA IN LDR PROSTATE BRACHYTHERAPY. PRELIMINARY RESULTS. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71672-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
33
|
Vara J, Sarasa J, Iglesias T, Chavez A, Prieto I, Luna J, Oliveira J, Pérez A. EP-1232 INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN EYELID-ORBITAL REGION. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71565-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
34
|
Zeballos AC, Prieto I, Pardo J, Luna J, Olivera J, Iglesias T, Vara J, Díaz C, Perez A. EP-1243 MERKEL CELL CARCINOMA (MCC); TREATMENT NOMOGRAMS NEEDED. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71576-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
35
|
Luna J, Moon Y, Liu K, Cespedes S, Spitalnik S, Paik M, Sacco R, Elkind M. High Sensitivity C-Reactive Protein to Interleukin 6 Ratio and Ischemic Stroke Risk in a Multi-Ethnic Cohort: The Northern Manhattan Study (S13.003). Neurology 2012. [DOI: 10.1212/wnl.78.1_meetingabstracts.s13.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
36
|
Luna J, Moon Y, Liu K, Cespedes S, Spitalnik S, Paik M, Sacco R, Elkind M. High Sensitivity C-Reactive Protein to Interleukin 6 Ratio and Ischemic Stroke Risk in a Multi-Ethnic Cohort: The Northern Manhattan Study (IN3-1.001). Neurology 2012. [DOI: 10.1212/wnl.78.1_meetingabstracts.in3-1.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
37
|
Luna J, Iglesias T, Olivera J, Vara J, Prieto I, Chavez A, Perez A, Cristobal J, Di Fiore H, Martinez O. Laparoscopic Para-aortic Lymphadenectomy (LPL) In Staging Of Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
38
|
Alvarado A, Feltes N, Pardo J, Olivera J, Luna J, Vara J, Prieto I, Perez A. Complete Pathological Response After Preoperative Chemo-radiation (PCRT) In Rectal Cancer: 10 Years Evolution. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
39
|
Pardo J, Murcia M, Biete A, Alvarado A, Feltes N, Olivera J, Luna J, Vara J, Prieto I, Perez A. Response to Palliative Radiotherapy (PRT) in Patients (PTS) with Painful Bone Metastases depending on the site of Metastases and the Primary Tumor. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.1904] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
40
|
Castellsagué X, Muñoz N, Pitisuttithum P, Ferris D, Monsonego J, Ault K, Luna J, Myers E, Mallary S, Bautista OM, Bryan J, Vuocolo S, Haupt RM, Saah A. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer 2011; 105:28-37. [PMID: 21629249 PMCID: PMC3137403 DOI: 10.1038/bjc.2011.185] [Citation(s) in RCA: 232] [Impact Index Per Article: 17.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2011] [Revised: 04/18/2011] [Accepted: 04/26/2011] [Indexed: 01/13/2023] Open
Abstract
BACKGROUND Previous analyses from a randomised trial in women aged 24-45 years have shown the quadrivalent human papillomavirus (qHPV) vaccine to be efficacious in the prevention of infection, cervical intraepithelial neoplasia (CIN), and external genital lesions (EGLs) related to HPV 6/11/16/18. In this report, we present end-of-study efficacy, safety, and immunogenicity data with a median follow-up time of 4.0 years. METHODS We enrolled 3819 24-45-year-old women with no history of cervical disease or genital warts in the past 5 years. Women received quadrivalent vaccine or placebo at day 1, and at months 2 and 6. Ascertainment of CIN/EGL was accomplished through Pap testing, genital inspection, and cervicovaginal sampling (every 6 months). The main analysis was conducted in a per-protocol efficacy population (that received three doses, was naive to the relevant HPV types at day 1, and remained free of infection through month 7). Efficacy was also estimated in other naive and non-naive populations. RESULTS Vaccine efficacy against the combined incidence of persistent infection, CIN/EGL related to HPV6/11/16/18 in the per-protocol population was 88.7% (95% CI: 78.1, 94.8). Efficacy for women who were seropositive and DNA negative for the relevant vaccine HPV type at the time of enrolment who received at least 1 dose was 66.9% (95% CI: 4.3, 90.6). At month 48, 91.5, 92.0, 97.4, and 47.9% of vaccinated women were seropositive to HPV 6/11/16/18, respectively. No serious vaccine-related adverse experiences were reported. CONCLUSIONS The qHPV vaccine demonstrated high efficacy, immunogenicity, and acceptable safety in women aged 24-45 years, regardless of previous exposure to HPV vaccine type.
Collapse
Affiliation(s)
- X Castellsagué
- Unit of Infections and Cancer, Cancer Epidemiology Research Program, IDIBELL, Institut Català d'Oncologia-ICO, CIBER-ESP, L'Hospitalet de Llobregat, Catalonia 08907, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Luna J, Iglesias T, Rincón M, Olivera J, Mateos M, Vara J, Prieto I, Feltes N, Alvarado A, Pardo J, Pérez A, Mena A. ASSESSING THE EFFICIENCY OF GLUTAMINE TREATMENT FOR PREVENTING ACUTE OESOPHAGITIS IN LUNG CANCER PATIENTS TREATED WITH RADIOCHEMOTHERAPY. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)71791-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
42
|
Olivera J, Chavez A, Mateos M, Iglesias T, Luna J, Vara J, Feltes N, Alvarado A, Pardo J, Pérez A. PREVENTING ACUTE RECTITIS AND CYSTITIS WITH GLUTAMINE IN PROSTATE CANCER PATIENTS TREATED WITH RADIOTHERAPY. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)71808-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
43
|
Feltes N, Alvarado A, Pardo J, González J, Pérez A, Olivera J, Luna J, Sole J, Vara J, Alcover J. ACUTE TOXICITY DUE TO RADIOTHERAPY IN RECTAL CANCER PATIENTS OLDER THAN 80 YEARS, TREATED WITH 5 TIMES/5 GY SCHEDULE WITHOUT SURGERY. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)71789-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
44
|
Pardo J, Murcia M, Alvarado A, Feltes N, Hernández M, Pérez A, Olivera J, Luna J, Vara J, Alvarez A, Soto R, Biete A. PREVENTING SKIN TOXICITY IN BREAST CANCER PATIENTS UNDERGOING RADIOTHERAPY WITH AN EMULSION CONTAINING HYALURONIC ACID, CHONDROITIN SULFATE, ALOE VERA, CARROT OIL, VITAMIN F AND VITAMIN E. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)71809-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
45
|
Sardon H, Irusta L, Fernández-Berridi MJ, Luna J, Lansalot M, Bourgeat-Lami E. Waterborne polyurethane dispersions obtained by the acetone process: A study of colloidal features. J Appl Polym Sci 2010. [DOI: 10.1002/app.33308] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
46
|
Lindert J, Luna J, Torres-Gonzalez F, Ioannidi-Kappolo E, Lamura G, Stankunas M, Soares J. Gewalt gegen Menschen über 60 Jahre und Depression und Angst – Ergebnisse einer europäischen Studie. Gesundheitswesen 2010. [DOI: 10.1055/s-0030-1266576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
47
|
Sirgo G, Claramonte R, Chánovas M, Esteban F, Forcadell I, Luna J, Masdeu G, Ramón Vázquez J, Artigas A. [Dendritic cells in sepsis: an approach to post-infectious immunosuppression]. Med Intensiva 2010; 34:559-66. [PMID: 20034705 DOI: 10.1016/j.medin.2009.11.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2009] [Revised: 10/16/2009] [Accepted: 11/08/2009] [Indexed: 12/24/2022]
Abstract
Dendritic cells (DCs) play a decisive role in the immune system, especially in the initial events that determine coordination between the innate and adaptive response. Moreover, they are antigen-presenting cells which, through contact with T cells, determine the type of immune responses towards inflammatory or anti-inflammatory. Currently, the hypothesis that attributes importance to the development of a post-infectious immunosuppression in the prognosis of the septic patient is growing stronger. It has been possible to verify the role played by these cells in this type of immunosuppression by the significant decrease in the number of DCs and by the dysfunctions in the functional capacity that include, on the one hand, the abnormal cytokine production and, on the other hand, the alterations in communication between the DCs and T cells that constitute an essential immunological fact. Further research into the knowledge regarding the DCs, in the context of severe infection, may help to consolidate some encouraging data that indicate these cells as: 1) an effective tool for monitoring the acute infection, 2) a discriminatory variable that may help determine the risk of nosocomial infection and 3) in a longer term, a treatment target that would restore the immunological abnormalities that occur in sepsis.
Collapse
Affiliation(s)
- G Sirgo
- UMI, Hospital Verge de la Cinta, Tortosa, Tarragona, España.
| | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Gutierrez OL, Ocampo CL, Aguilera JR, Luna J, Sumano LH. Pharmacokinetics of disodium-fosfomycin in mongrel dogs. Res Vet Sci 2007; 85:156-61. [PMID: 17910966 DOI: 10.1016/j.rvsc.2007.08.011] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2007] [Revised: 06/12/2007] [Accepted: 08/21/2007] [Indexed: 11/25/2022]
Abstract
Pharmacokinetic variables of fosfomycin were determined after administration of buffered disodium-fosfomycin intravenously (IV), intramuscularly (IM), subcutaneously (SC) and orally (PO), in mongrel dogs, at 40 and 80 mg/kgday for three days. Renal integrity was also assessed by measuring key serum variables. Day 1, day 2 and day 3 plasma concentration vs. time profiles were undistinguishable, but there appears to be a lineal increase in serum concentrations vs. time with the dose. A non-accumulative kinetic behavior was observed after three days with both doses and most pharmacokinetic variables remain unaltered. Considering a MIC range from 1 mirog/mL to 16 microg/mL of fosfomycin in serum for sensitive bacteria, and a negligible plasma protein binding of fosfomycin (<0.5%), useful plasma concentrations can only be achieved after the SC injection of 80 mg/kg every 12h, having a C(max)=18.96+/-0.3 microg/mL; a T(1/2beta)=2.09+/-0.06 microg/mL and a bioavailability of 84-85%. No alterations were observed in serum variables of kidney-related biochemical values.
Collapse
Affiliation(s)
- O L Gutierrez
- Departamento de Fisiología y Farmacología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de Mexico, Avenida Universidad 3000, Coyoacán, Mexico City 04510, Mexico
| | | | | | | | | |
Collapse
|
49
|
Robledo JA, Mejía GI, Morcillo N, Chacón L, Camacho M, Luna J, Zurita J, Bodon A, Velasco M, Palomino JC, Martin A, Portaels F. Evaluation of a rapid culture method for tuberculosis diagnosis: a Latin American multi-center study. Int J Tuberc Lung Dis 2006; 10:613-9. [PMID: 16776447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2023] Open
Abstract
SETTINGS Tuberculosis (TB) diagnostic laboratories in Latin America. OBJECTIVES Evaluation of thin-layer agar (TLA) compared to Löwenstein-Jensen (LJ) culture for the diagnosis of TB. DESIGN Phase II prospective study in six laboratories. Samples included sputum and extra-pulmonary specimens from patients with a clinical diagnosis of TB. Respiratory samples were decontaminated using NaOH/ NALC; all samples were centrifuged, stained with Ziehl-Neelsen for acid-fast bacilli (AFB), cultured on LJ and TLA and identified according to recommended procedures. Sensitivity and likelihood ratios (LR), growth detection time and contamination rate were calculated for both media. RESULTS A total of 1118 clinical specimens were studied. Cultures detected Mycobacterium tuberculosis in all AFB-positive samples, whereas for AFB-negative specimens LJ detected 3.2% and TLA 4.4%. Sensitivity was 92.6% (95%CI 87.9-95.9) and 84.7% (95%CI 78.8-89.0) for TLA and LJ, respectively. Positive and negative LRs were similar. Contamination was 5.1% for TLA and 3.0% for LJ. Median time to detection of a positive culture was 11.5 days (95%CI 9.3-15.0) for TLA and 30.5 days (95%CI 26.9-39.0) for LJ (P < 0.0001). CONCLUSION Difference in the characteristics of the participating laboratories, the disease prevalence and the number and type of specimens processed did not affect the overall performance of TLA as compared to LJ, supporting the robustness of the method and its feasibility in different laboratory settings.
Collapse
Affiliation(s)
- J A Robledo
- Unidad de Bacteriología y Micobacterias, Corporación para Investigaciones Biológicas-CIB, Medellín, Antioquia, Colombia.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Soto C, Mena R, Luna J, Cerbón M, Larrieta E, Vital P, Uría E, Sánchez M, Recoba R, Barrón H, Favari L, Lara A. Silymarin induces recovery of pancreatic function after alloxan damage in rats. Life Sci 2004; 75:2167-80. [PMID: 15325843 DOI: 10.1016/j.lfs.2004.04.019] [Citation(s) in RCA: 69] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2003] [Accepted: 04/07/2004] [Indexed: 11/30/2022]
Abstract
Alloxan has been widely used to produce experimental diabetes mellitus syndrome. This compound causes necrosis of pancreatic beta-cells and, as is well known, induces oxidant free radicals which play a relevant role in the etiology and pathogenesis of both experimental and human diabetes mellitus. Previously we have reported hypoglycemic and antilipoperoxidative actions of silymarin in serum and pancreatic tissue respectively. The aim of this study was to test whether silymarin could reduce the hyperglycemia and revert the pancreatic damage in alloxan treated rats, tested with silymarin in two protocols: using both compounds simultaneously for four or eight doses, or using the compound 20 days after alloxan administration for 9 weeks. Serum glucose and insulin were determined, and pancreatic fragments were used for histology and insulin immunohistochemistry. Pancreatic islets were isolated to assess insulin and Pdx1 mRNA expression by RT-PCR. Our results showed that 72 hours after alloxan administration, serum glucose increased and serum insulin decreased significantly, whereas pancreatic tissue presented morphological abnormalities such as islet shrinkage, necrotic areas, loss of cell organization, widespread lipoid deposits throughout the exocrine tissue, and loss of beta cells, but insulin and glucagon immunoreactivity was scattered if any. In contrast the pancreatic tissue and both insulin and glucose serum levels of rats treated with silymarin were similar to those of control animals. In addition, insulin and glucagon immunoreactive cells patterns in Langerhans islets were also normal, and normal insulin and Pdx1 mRNA expression patterns were detected during pancreatic recovery in Langerhans islets. The overall results suggest that silymarin induces pancreatic function recovery demonstrated by insulin and glucagon expression protein and normoglycemia after alloxan pancreatic damage in rats.
Collapse
Affiliation(s)
- C Soto
- Department of Biological Systems, Metropolitan Autonomous University, Mexico.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|